Multi-cancer screening in APAC gains momentum amidst economic growth

The global market for multi-cancer screening is expected to reach $2.72b by 2030.

Asia-Pacific’s (APAC) economic growth has accelerated the deployment of multi-cancer screening technologies, according to a report by 360iResearch.

The report revealed that China’s economic incline has created a surge in healthcare spending, particularly on AI adoption and genetic testing innovations under the Healthy China 2030 plan.

Meanwhile, Japan’s healthcare strategy prioritises multi-cancer screening for early detection efforts.

ALSO READ: NUH to establish health centre for early cancer detection in 2025

Moreover, India is in the early stages of adopting the technology with its government initiatives such as the National Cancer Screening Program.

According to the report, multi-cancer screening utilises advances in liquid biopsies, genetic testing, and artificial intelligence (AI)  to facilitate timely and more effective treatment paths.

Its global market is expected to reach $2.72b at a compound annual growth rate (CAGR) of 9.9% by 2030.